Details of the Drug

General Information of Drug (ID: DMG02ET)

Drug Name
KP-1461
Synonyms KP1461; 943540-08-7; C522536000
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Phase 2 [1]
Pneumococcal infection CA00-CA40 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C16H28N4O6
Canonical SMILES
CCCCCCCOC(=O)NC1=NCN(C(=O)N1)C2CC(C(O2)CO)O
InChI
1S/C16H28N4O6/c1-2-3-4-5-6-7-25-16(24)19-14-17-10-20(15(23)18-14)13-8-11(22)12(9-21)26-13/h11-13,21-22H,2-10H2,1H3,(H2,17,18,19,23,24)/t11-,12+,13+/m0/s1
InChIKey
SZWIAFVYPPMZML-YNEHKIRRSA-N
Cross-matching ID
PubChem CID
51003457
CAS Number
815588-85-3
TTD ID
D0X0FU
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT00504452) Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients. U.S. National Institutes of Health.